Aeolus Pharmaceuticals (AOLS)

[jimbob4stocks]

Aeolus sold their 35% stake in Gencaro to Arca Biopharma. Curious how much they got for it.

ARCA expects G&A expenses in 2017 to be higher than in 2016 due to increased administrative activities to support the GENETIC-AF clinical trial and costs incurred in the fourth quarter of 2017 for the acquisition of certain Gencaro license rights from Aeolus Pharmaceuticals, Inc. which previously held certain royalty rights on the Gencaro program.

https://www.biospace.com/article/releases/arca-biopharma-announces-third-quarter-2017-financial-results-and-provides-business-update/

We were previously developing bucindolol for the treatment of heart failure, but development was discontinued in 1999. Commercial rights to bucindolol are owned by CPEC, LLC, a limited liability company ("CPEC"), of which we own 35% and Endo Pharmaceuticals (formerly Indevus Pharmaceuticals), Inc. owns 65%.

https://www.sec.gov/Archives/edgar/data/1261734/000110262415001827/aeolus10k.htm